Iniciar sesión

Noa Kaynan

Preclinical Research Department

Novocure Ltd., Haifa, Israel

BIOGRAPHY

Noa Kaynan has not added Biography.

If you are Noa Kaynan and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.

PLoS pathogens Aug, 2013 | Pubmed ID: 23966863

Cytokine secretion and NK cell activity in human ADAM17 deficiency.

Oncotarget Dec, 2015 | Pubmed ID: 26683521

Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.

The Journal of experimental medicine Aug, 2016 | Pubmed ID: 27503073

INSTITUTIONS

Novocure Ltd., Haifa, Israel

JOVE ARTICLES

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Yaara Porat¹,

Moshe Giladi¹,

Rosa S. Schneiderman¹,

Roni Blat¹,

Anna Shteingauz¹,

Einav Zeevi¹,

Mijal Munster¹,

Tali Voloshin¹,

Noa Kaynan¹,

Orna Tal¹,

Eilon D. Kirson²,

Uri Weinberg³,

Yoram Palti²

¹Preclinical Research Department, Novocure Ltd., Haifa, Israel,

², Novocure Ltd., Haifa, Israel,

³, Novocure GmbH, Lucerne, Switzerland

Cancer Research

Privacidad

Condiciones de uso

Políticas

Contáctenos

RECOMIENDE A LA BIBLIOTECA

BOLETINES de JoVE

Investigación

JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo

Educación

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Faculty Site

Autores

Descripción
Proceso de publicación
Comité editorial
Ámbito y políticas
Revisión por pares
Preguntas frecuentes
Enviar

Bibliotecarios

Descripción
Testimonios
Suscripciones
Acceso
Recursos
Junta Asesora de Bibliotecarios
Preguntas frecuentes

ACERCA DE JoVE

Descripción
Liderazgo
Blog
JoVE Help Center

Noa Kaynan

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Preclinical Research Department

Novocure Ltd., Haifa, Israel

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Preclinical Research Department